What's Happening?
Health benefit costs for employers are projected to rise by 6.7% in 2026, according to data from Mercer, a consulting firm. This increase is slightly higher than the previous estimate of 6.5% and marks a continuation of a trend that has seen health benefit costs rise by 6%
in 2025. The rising costs are putting significant pressure on employers' benefit budgets, prompting them to explore various strategies to manage these expenses. Traditional methods, such as increasing premiums and deductibles, are becoming unsustainable. As a result, employers are considering alternative approaches, including non-traditional medical plans and pharmacy benefit changes. The SHRM 2026 Employee Benefits Survey indicates a decline in the number of employers bundling prescription drug coverage with health insurance, with more opting for independent pharmacy management programs.
Why It's Important?
The rising cost of health benefits is a critical issue for both employers and employees. For employers, these costs represent a significant portion of their overall expenses, and managing them is crucial for maintaining financial stability. For employees, the affordability of health benefits is a major concern, as increased costs can lead to higher out-of-pocket expenses. The shift towards non-traditional medical plans and independent pharmacy management programs reflects a broader trend of employers seeking innovative solutions to control costs while maintaining the quality of benefits. This trend could lead to significant changes in how health benefits are structured and delivered, impacting millions of workers across the U.S.
What's Next?
Employers are likely to continue exploring and implementing new strategies to manage rising health benefit costs. This may include further adoption of non-traditional medical plans, such as high-performance networks and variable copay plans, which offer lower cost-sharing for employees using pre-selected providers. Additionally, employers may increasingly scrutinize the value of high-cost medications, such as GLP-1 drugs, and adjust coverage policies accordingly. These changes could lead to a more personalized approach to health benefits, with a focus on cost-effectiveness and value for both employers and employees.
